Fairvalue-Calculator Fairvalue-Calculator
EN DE

Guardian Pharmacy Services, Inc (GRDN) Fair Value & Analysis

Healthcare · US · Market cap $2.7B

Price$39.19
Fair Value$22.73
Upside-42.0%
Quality91/100
Evidence: High Range $16.83 – $28.42

Analysis

Guardian Pharmacy Services, Inc (GRDN) currently trades at $39.19, while our model-based Fair Value estimate is $22.73 — implying the stock looks roughly 42.0% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) -74% Fresenius SE (FSNUY) -27% 5225 (5225) -64% IHHHF (IHHHF) -26% Tenet Healthcare Corporation (THC) +70% Rede D'Or São Luiz S.A (RDOR3) +42%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.